1623 Capital’s Kodiak Sciences KOD Stock Holding History

1623 Capital’s Portfolio KOD Stock Details KOD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,349	Closed	-$623K	–	61
2021 Q4	$623K	Buy	7,349 +2,093	+40%	+$213K	0.23%	51
2021 Q3	$504K	Hold	5,256	–	–	0.2%	51
2021 Q2	$489K	Buy	5,256 +3,314	+171%	+$318K	0.19%	53
2021 Q1	$220K	Buy	+1,942	New	+$265K	0.09%	56

Other funds holding KOD

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

1623 Capital's KOD Position: Q1 2022 in Review

1623 Capital sold out of Kodiak Sciences (KOD) in Q1 2022, closing a stake of 7,349 shares — an estimated $623K sold.

1623 Capital first reported a position in KOD in Q1 2021 and held it in 4 quarters. The position peaked at $623K in Q4 2021. 142 funds tracked by Wall St. Rank hold KOD as of Q1 2022.

1623 Capital reported no remaining Kodiak Sciences position as of Q1 2022 after selling out during the quarter.
1623 Capital sold 7,349 Kodiak Sciences shares in Q1 2022, an estimated $623K.
1623 Capital first reported a position in Kodiak Sciences in Q1 2021 and held it in 4 quarters.
1623 Capital's Kodiak Sciences position peaked at $623K in Q4 2021.
142 funds tracked by Wall St. Rank held Kodiak Sciences as of Q1 2022.

Based on 1623 Capital's 13F filing for Q1 2022, filed 13 May 2022.